"Our research shows that long development times are an unlikely factor in rising drug prices," said Dr. Salomeh Keyhani, an assistant professor of health policy at Mount Sinai School of Medicine in New York who led the study.
"Drug companies will price new drugs at the highest price that the market will bear, not based on drug development times."
No comments:
Post a Comment